Imagine being tasked with ensuring an unborn child is protected from a life-threatening disease, knowing that every action you take determines whether the baby will be born healthy or not.This ...

Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...

The primary outcome was fold rise in antibody titers from baseline to four weeks; seroconversion was defined as a fourfold or greater rise in preF immunoglobulin G (IgG) at four weeks. Overall ...